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Abstract A bacteriophage, designated UZ1 and showing
lytic activity against a clinically important strain (BE1) of
Enterobacter aerogenes was isolated from hospital sew-
age. The stability and lytic activity against this strain under
simulated gastro-intestinal conditions was evaluated. After
addition of bacteriophage UZ1 to a liquid feed at gastric
pH 2, the phage was immediately inactivated and could
not be recovered. However, by use of an antacid to
neutralize stomach acidity, no significant changes in phage
titer were observed after 2 h incubation at 37 °C. After
supplementing pancreatic juice and further incubation for
4 h, the phage titer remained stable. The persistence of
UZ1 in a mixed microbial ecosystem that was representa-
tive for the large intestine was monitored using an in vitro
simulation of the human intestinal microbial ecosystem. A
pulse administration of bacteriophage UZ1 at a concen-
tration of 105 plaque-forming units (PFU)/ml to reactor 3
(which simulates the ascending colon) showed that, in the
absence of the host, bacteriophage UZ1 persisted for
13 days in the simulated colon, while the theoretical
washout was calculated at 16 days. To assess its lytic
activity in an intestinal microbial ecosystem, a green
fluorescent protein (gfp)-labeled E. aerogenes BE1 strain
was constructed and gfp-specific primers were designed in
order to quantify the host strain using real-time PCR. It
was observed that bacteriophage UZ1 was able to replicate
and showed lytic activity against E. aerogenes BE1/gfp in
an intestinal microbial ecosystem. Indeed, after 17 h a
2 log unit reduction of E. aerogenes BE1/gfp was
measured as compared with the assay without bacterio-
phage UZ1, while the phage titer increased by 2 log units
at an initial multiplicity of infection of 0.07 PFU/colony-
forming unit. This is the first report of an in vitro model to
study bacteriophage activity in the complex intestinal
microbial community.
Introduction
Bacteriophages (phages), viruses with a bacterial host, are
ubiquitous and highly diverse. They have been isolated
from a wide variety of environments, including seawater
(Borsheim 1993), soil (Ashelford et al. 2003), sewage
(Ewert and Paynter 1980), food products (Gautier et al.
1995; Josephsen and Neve 1998; Yoon et al. 2002), and
feces (Furuse et al. 1983). The property of phages to infect
and lyse bacterial cells led to the therapeutic use of
bacteriophages, the so-called phage therapy. The first
report of phage therapy was by Felix d’Herelle in 1919 to
treat a patient with dysentery (Summers 1999). With the
advent and success of antibiotics, phage therapy passed
into oblivion. However, in the former Soviet Union the
therapeutic use of bacteriophages was further developed,
which resulted in a number of reports on the use of phage
therapy in English literature (Slopek et al. 1987;
Chanishvili et al. 2001; Sulakvelidze et al. 2001).
Experiments on laboratory animals and the use of phage
therapy in veterinary medicine have also been reported
(Smith and Huggins 1983; Berchieri et al. 1991; Soothill
1992; Ramesh et al. 1999; Biswas et al. 2002).
In contrast, the human intestinal tract has been
extensively studied and several in vitro systems have
been developed (Molly et al. 1993; Hack and Selenka
1996; Macfarlane et al. 1998; Minekus et al. 1999; De
Boever et al. 2001). In vitro models offer defined
experimental conditions and easy sampling. Also, the
lack of ethical constraints when using in vitro model
systems over human or animal subjects is an advantage.
The simulation of the human intestinal microbial ecosys-
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tem (SHIME) is a five-stage reactor developed by Molly et
al. (1993) and optimized by De Boever et al. (2001).
As a model pathogen in this study, a clinical isolate of
Enterobacter aerogenes, strain BE1, was used. Species of
Enterobacter are opportunistic pathogens and rarely cause
disease in the otherwise healthy individual. Most of these
organisms are innately resistant to conventional antimi-
crobial agents and have the ability to rapidly develop
resistance to newer agents. Among the Enterobacter
genus, E. cloacae and E. aerogenes are the two species
most frequently isolated from clinical samples; and these
organisms belong to the normal digestive microbiota
(Sanders and Sanders 1997). Most nosocomial Entero-
bacter infections appear to arise indigenous from a
previously colonized site in the patient (Flynn et al.
1987; Galili et al. 1992; Fryklund et al. 1994). Coloniza-
tion of the gastro-intestinal tract and other body sites with
Enterobacter spp frequently occurs in the seriously ill
patient, especially after prior antibiotic therapy (Gaston
1988; Falkiner 1992). From a survey in Belgian hospitals
from 1996 to 1998, the data collected suggested a
nationwide dissemination of two epidemic multiresistant
E. aerogenes strains (BE1, BE2) in Belgium. The BE1
type was indistinguishable from a previously described
epidemic strain in France (De Gheldre et al. 2001). Those
facts indicate that the number of clinically important
strains throughout Europe may be rather limited such that
development of a controlling strategy for nosocomial E.
aerogenes infections by host-specific bacteriophages may
be feasible.
The objective of the present study was to develop an in
vitro model to investigate bacteriophage stability and
activity under gastro-intestinal conditions. The model
consists of a bacteriophage (UZ1) and its host, a clinical
isolate of E. aerogenes. Different aspects affecting bacte-
riophage stability during transit through the gastro-intes-
tinal tract were evaluated, i.e. resistance to stomach
acidity, bile, and pancreatin. Persistence in an intestinal
microbial ecosystem was determined using the SHIME.
Bacteriophage replication and host titer were monitored in
a microbial community representative of that in the large
intestine. This is the first report of an in vitro model study
on bacteriophage activity in the complex microbial
intestinal community.
Materials and methods
Bacteriophage UZ1
Bacteriophage UZ1 was isolated from hospital sewage (University
Hospital, Ghent, Belgium), using an enrichment procedure. Sewage
samples were centrifuged for 5 min at 10,000 g and the supernatant
was filter-sterilized (0.22 µm). From the supernatant, aliquots of
8 ml were supplemented with 1 ml of 10× LB medium, 1 ml of a
mid-log phase culture of E. aerogenes BE1, and incubated on a
shaker for 4 h at 37 °C. LB medium composition was (per liter):
10 g trypton (Applichem, Darmstadt, Germany), 5 g yeast extract
(Applichem), and NaCl. After enrichment, samples were centrifuged
for 5 min at 10,000 g and the supernatant was filter-sterilized
(0.22 µm). To detect phages, the soft agar layer method described by
Adams (1959) was applied, using serially dilutions of the superna-
tant in SM medium (50 mM Tris-HCl, pH 7.5, 100 mM NaCl,
10 mM MgSO4, 0.01% gelatin). In brief, 100 µl of serially diluted
supernatant was mixed with 400 µl of a mid-log phase E. aerogenes
BE1 culture and 2.5 ml of 0.5% agar (Federa, Brussels, Belgium).
The mixture was poured over a Petri dish with LB agar (LB medium
supplemented with 15 g agar/l) and incubated for 16 h at 37 °C.
Single plaques were picked and isolated again three times to ensure
pure phage strains.
To prepare phage stock, a single plaque was diluted in 500 µl of
SM medium and the soft agar layer method was used as described
above, using 100 µl of the diluted plaque. Soft agar layers were
removed from plates and diluted in 10 ml of SM medium. Phages
were separated by centrifugation for 10 min at 10,000 g and filter-
sterilized (0.22 µm).
For the determination of phage titers, serial dilutions were plated
using the soft agar layer technique, as described above.
Restriction analysis and transmission electron microscopy
Bacteriophage DNA was extracted according to Hambly et al.
(2001). Restriction analysis and gel electrophoresis of bacteriophage
DNA were executed as described by Sambrook and Russell (2001).
The restriction enzymes used were DraI, MspI, and EcoRI
(Amersham Biosciences, Roosendaal, The Netherlands).
For transmission electron microscopy, bacteriophages were
applied to copper-mesh grids and negatively stained with 2% uranyl
acetate.
Host-range of bacteriophage UZ1
The host-range of bacteriophage UZ1 was determined by spotting
phage UZ1 on bacterial lanes of E. aerogenes BE1 and five other
strains (E. aerogenes BE2, E. aerogenes ATCC 13048, E. cloacae
LM W011, Escherichia coli ESBL 111, E. coli ESBL 112). After
overnight incubation at 37 °C, bacterial lanes were screened for
plaque formation. The clinical isolates were supplied from the
collection of the Department of Clinical Chemistry, Microbiology
and Immunology (Ghent University, Belgium).
Effect of pH, bile salts, and pancreatin on bacteriophage UZ1
The effect of pH was examined by diluting phage UZ1 to a final
concentration of 6.2±0.3×105 plaque-forming units (PFU)/ml in SM
medium set to different pH levels (pH 2, 4, 6, 7, 9) with 1 N NaOH
or 1 N HCl. Samples were taken at the start of the experiment and
after 1 h of incubation at 37 °C. Phage titers were determined by the
soft agar layer technique, as described above.
The effect of antacid, bile salts and pancreatin on bacteriophage
UZ1 was studied as follows. In an Erlenmeyer flask (500 ml vol.),
1 ml of a phage stock at 8 log PFU/ml was added to 140 ml of a
liquid reactor feed. The feed composition was identical to the
SHIME reactor feed (per liter): 1 g arabinogalactan, 2 g pectin, 1 g
xylan, 3 g potato starch, 0.4 g glucose, 3 g yeast extract, 1 g
peptone, 4 g mucin, and 0.5 g cystein. The feed was autoclaved and
the pH of the feed was set to 2 with 6 N HCl. For the treatment with
antacid, 1.75 g NaHCO3was added prior to inoculation with phage.
After incubation for 2 h at 37 °C with shaking, 60 ml of pancreatic
fluid was supplemented consisting of (per liter): 1.5 g pancreatin
(Sigma), 6 g bile (oxgall; Difco), and 12.5 g NaHCO3. Erlenmeyers
were incubated for another 4 h at 37 °C with shaking. Samples
(1 ml) were taken and pH was measured at the start, after 2 h, and at
the end of the incubation. Samples were centrifuged for 5 min at
10,000g and the supernatant was used for the determination of
phage titer as described above.
466
E. aerogenes BE1/gfp
Marking with gfp
The genes for the green fluorescent protein (gfp) fluorochrome and
kanamycin resistance were inserted into the chromosome of E.
aerogenes BE1. This was done by means of a biparental mating
between E. coli S17-1 λpir (pUTgfp; Boon et al. 2001) and E.
aerogenes BE1, with selection on LB plates with tetracyclin (20 mg/
l) and kanamycin (50 mg/l). The obtained marked cells were
selected on their GFP fluorescence (excitation at 396/476 nm,
emission at 508 nm) by a Dark Reader illuminator (Clare Chemical
Research, Denver, Colo.). The infectivity of bacteriophage UZ1 was
not affected after labeling E. aerogenes BE1 with the gfp gene.
Detection and quantification of the gfp gene
Total DNA extractions from bacterial culture of E. aerogenes BE1/
gfp and samples from the lytic activity assays were performed using
the method adapted from Griffiths et al. (2000) and Kowalchuck et
al. (1998), as described by Boon et al. (2002). The primers for real-
time amplification of the Aequorea victoria gfp gene (GenBank
accession number U73901.1) were constructed by the use of Primer
Express ver. 2.0 (Applied Biosystems, Nieuwekerk a/d Ijssel, The
Netherlands). The specificity of the designed primers was checked
using the BLAST server of the National Center for Biotechnology
Information, using the BLAST algorithm (Altschul et al. 1997). The
forward primer, GFP-F-272–293 (3′-GCCATGCCAGAAGGT-
TATGTTC-5′; positions 272–293) and reverse primer GFP-R-356–
332 (3′-CAAACTTGACTTCAGCTCTGGTCTT-5′; positions 332–
356) amplified a PCR fragment of 85 bp.
Real-time quantitative PCR was performed using an ABI Prism
SDS 7000 instrument (PE Applied Biosystems, Nieuwerkerk a/d
Ijssel, The Netherlands). All reagents used to perform real-time PCR
detection were purchased from Applied Biosystems. The amplifi-
cation reactions were carried out with Sybr Green PCR master mix
containing AmpliTaq Gold DNA polymerase, AmpErase uracil-N-
glycosylase, Sybr GreenI, deoxynucleoside triphosphates with
dUTP, and passive reference and optimized buffer components.
The final concentrations of each oligonucleotide in the PCR mixture
were 300 nM. The total volume of the PCR mixture was 25 µl,
including 1 µl of DNA template, in MicroAmp Optical 96-well
reaction plates with optical caps, and the PCR was carried out
according to the instructions of the manufacturer. The PCR
temperature program was as follows: 50 °C for 2 min and 95 °C
for 10 min, followed by 40 cycles of 95 °C for 15 s, and 60 °C for
1 min. The concentrations of the primers and probes were optimized
as described in the TaqMan universal PCR master mix protocol
(Applied Biosystems).
The increase in emission intensity was measured during the
amplification reaction by the ABI PRISM 7000 sequence detection
system (SDS). Data acquisition and analysis were handled by ABI
PRISM 7000 SDS software ver. 1.0 (Applied Biosystems). Briefly, a
threshold is assigned to the log phase of product accumulation. The
point at which the threshold crosses the amplification curve is
defined as a cycle threshold value, termed CT. With increasing target
quantity in the PCRs, the CT value decreases linearly and thus CT
values can be used as quantitative measurements of the input target
amount (Heid et al. 1996).
The comparative CT method was used for quantitative analyses.
Standard curves were constructed after real-time PCR amplification
of DNA extracts of different E. aerogenes BE1/gfp cell numbers
(n=4) ranging from 5.3×107 to 5.3×104 colony-forming units (CFU)/
well. The R2 value was greater than 0.99 for the standard curves and
a slope of −3.67 was generated. Based on the standard curve, the
exact number of E. aerogenes BE1/gfp cells in the DNA extracts
could be determined
Simulator of the human intestinal microbial ecosystem
The SHIME reactor setup was based on the adult SHIME (Molly et
al. 1993; De Boever et al. 2001). In brief, the SHIME was designed
to maintain a microbial community that is representative of that in
the human intestinal system. The SHIME consisted of five
sequential reactors that represent the different parts of the intestinal
tract: stomach and duodenum (reactor 1), jejunum and ileum
(reactor 2), ascending colon (reactor 3), transverse colon (reactor 4),
and descending colon (reactor 5). The first two reactors were of the
fill-and-draw principle, while the last three were continuous stirred
reactors with pH control. The overall residence time of the last three
reactors, simulating the large intestine, was 76 h. The temperature of
the system was kept at 37 °C by a thermostat and the system was
kept anaerobic by flushing with N2 for 15 min every day. Inoculum
preparation and reactor start-up were as described by De Boever et
al. (2001).
Persistence of bacteriophage UZ1 in the SHIME
A single dose of phage UZ1 was administrated to reactor 3 to a final
concentration of 1.0×105 PFU/ml. Samples were taken daily from
reactors 3, 4, and 5, centrifuged for 5 min at 10,000 g, and filter-
sterilized. Phage titer was determined by the soft agar layer
technique. The theoretical washout of inert particles was calculated
using a first-order kinetics model: Xt=X0×e
−kt, where Xt is the phage
concentration at time t, X0 is the initial phage concentration, and k is
determined by [(volume of feed/day)/volume of reactor 3].
Lytic activity assay
Experiments in triplicate were conducted in 100-ml penicillin bottles
incubated at 37 °C for 17 h. For lytic activity assays with SHIME
suspension, the reactor content was removed from reactor 5
(descending colon) and 50-ml aliquots were transferred to penicillin
bottles. E. aerogenes BE1/gfp and phage UZ1 were added to the
penicillin bottles at the start of the experiment at final concentrations
of 8.6±0.89×105 CFU/ml and 5.8±1.1×104 PFU/ml, respectively.
Phage titers were determined by the soft agar layer technique and E.
aerogenes BE1/gfp concentrations were determined by real-time
PCR, using primers specific for the gfp gene sequence.
Results
Host-range of bacteriophage UZ1
Phage UZ1 was found to be infective only for E.
aerogenes BE1 LMG 22092. No plaque formation was
observed on the other strains tested: E. aerogenes BE2
LMG 22093, E. aerogenes ATCC 13048, E. cloacae LM
W011 LMG 22094, E. coli ESBL 111 LMG 22095, and E.
coli ESBL 112 LMG 22096.
Tentative classification of bacteriophage UZ1
After restriction of phage DNA with DraI, the size of the
major bands were approximately 23,000 bp, 7,000 bp, and
4,000 bp (Fig. 1). Phage DNA could not be restricted with
EcoRI or MspI. Transmission electron microscopy re-
vealed phage particles having an isometric head with a
diameter of approximately 65 nm and a short non-
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contractile tail (Fig. 2). These morphological properties
and the estimated genome size of at least 34 kb correspond
to the T7-like phages of the genus Podovirida (Order:
Caudovirales).
Effect of pH, bile salts, and pancreatin on
bacteriophage UZ1
After 1 h incubation at 37 °C at different pH levels, there
were no significant differences (P>0.05) between the
initial phage titer of 6.2±0.3×105 PFU/ml and the phage
concentrations at pH 9, 7, 6, and 4. However, at pH 2, the
concentration of bacteriophage UZ1 dropped below the
detection limit (1.0×101 PFU/ml) immediately after the
addition of phage UZ1.
The effect of gastric acidity, bile salts, and pancreatin on
bacteriophage UZ1 after addition of antacid (1.75 g
NaHCO3) is given in Table 1. In the control reactors,
phages were immediately inactivated and no phages could
be detected throughout the incubation. However, in the
reactors with antacid added prior to the administration of
phage UZ1, there was no significant effect on the phage
concentration during the 6 h of incubation.
Persistence of bacteriophage UZ1 in the SHIME
The persistence of bacteriophage UZ1 in the simulated
large intestine (reactors 3, 4, and 5; Fig. 3) was evaluated
in the absence of the host, E. aerogenes BE1, and the
theoretical washout was calculated. Before addition of the
phage to the system, samples from the colon reactors were
taken and screened for the presence of phages infective for
E. aerogenes BE1. Since the soft agar layer technique
detected no such phages, it can be assumed that the phages
detected during the subsequent experiment were those
added, i.e. phage UZ1. The detection limit of this
experiment was 1.0×101 PFU/ml. Phage UZ1 could be
detected for 7 days in reactor 3, while the calculated
washout would have reached the detection limit after
9 days. For reactor 4, phage UZ1 was detectable until
day 12, while the theoretical washout was 14 days. Phage
UZ1 stayed detectable in reactor 5 for up to 13 days, while
calculated washout reached the detection limit on day 16.
Fig. 1 DraI restriction analysis
of DNA from phage UZ1. M
Lambda/HindIII marker. DNA
fragment size is indicated at the
right
Fig. 2 Transmission electron microscopy of bacteriophage UZ1.
Phage particles had an isometric head with a diameter of
approximately 65 nm with a short non-contractile tail
Table 1 Effect of stomach acidity, bile salts, and pancreatin on the
stability of phage UZ1. By the addition of pancreatic juice after 2 h
of incubation at 37 °C, the reactor volume increased from 140 ml to
200 ml and therefore the total number of plaque-forming units
(PFU) per reactor is given. For each treatment, antacid (1.75 g
NaHCO3) was added prior to the addition of bacteriophage UZ1
(1 ml of 8.4±0.1 log PFU/ml)
Time pH Phage UZ1
(h) (log PFU/reactor)
Treatment 0 6.62±0.04 8.3±0.06
Control 0 2.03±0.02 <3.1a
Treatment 2 6.67±0.04 8.3±0.03
Control 2 2.04±0.01 <3.1a
Treatment 6 8.58±0.12 8.2±0.05
Control 6 7.72±0.05 <3.3a
a No phages detected, <1PFU/100 µl
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Lytic activity assay
Lytic activity of bacteriophage UZ1 against E. aerogenes
BE1/gfp was determined both in a monoculture with LB
medium and in the presence of the microbiota from the
SHIME. Results are presented in Fig. 4. In the control
assay with phage UZ1, but without E. aerogenes BE1/gfp,
a limited inactivation of the phage was measured. Phage
concentrations dropped from 5.8±0.1×104 PFU/ml to 2.0
±0.1×104 PFU/ml for the assay with LB medium and 5.0
±0.7×103 PFU/ml in the SHIME suspension. In the control
assay with E. aerogenes BE1/gfp, but without phage UZ1,
an increase was detected from 8.6±0.9×105 CFU/ml to 1.1
±0.1×108 CFU/ml in the monoculture with LB medium
and 6.9±1.4×106 CFU/ml in the assay harboring a SHIME
microbial community. In the two assays with both phage
UZ1 and strain BE1/gfp, bacteriophage UZ1 was able to
replicate and the titer of strain BE1/gfp was below the
initial level at the start of the experiment. In the assay with
LB medium, the final concentration of E. aerogenes BE1/
gfp was 2.8±0.6×105 CFU/ml, while in the assay with the
SHIME suspension, the final concentration dropped to 5.9
±1.2×104 CFU/ml. Interestingly, although the phage titer
in the assay with LB was higher than in the assay with the
SHIME suspension, 1.4±0.1×108 PFU/ml and 7.4
±0.8×106 PFU/ml, respectively, the lytic effect in the
SHIME suspension was higher than in the LB medium.
Discussion
To our knowledge, this is the first report of a host-specific
bacteriophage infecting E. aerogenes. Phage UZ1 was
found to be infective only for the E. aerogenes strain BE1.
It is possible that the isolation and propagation procedures
had an influence on the very narrow host-range of phage
UZ1. Phage UZ1 was isolated using an enrichment
procedure, reisolated three times and further propagated
on a single host, E. aerogenes BE1. Jensen et al. (1998)
Fig. 3 Persistence of phage
UZ1 (plaque-forming units,
PFU) in the colon reactors (R3,
R4, R5) of the simulation of the
human intestinal microbial eco-
system (SHIME). The calcu-
lated theoretical washout
(R3theor, R4theor, R5theor) is
indicated by dotted lines. A
single dose (1.0×105 PFU/ml) of
phage UZ1 was added to reac-
tor 3 at day 1. The detection
limit was 1.0×101 PFU/ml.
Bacteriophage UZ1 was detect-
able up to days 7, 12, and 13 in
reactors 3, 4, and 5, respectively.
Theoretical washout reached the
detection limit after 9, 14, and
16 days in reactors 3, 4, and 5,
respectively. d Days
Fig. 4 Lytic activity assays were executed in LB medium with a
monoculture of Enterobacter aerogenes BE1/gfp or a SHIME
suspension harboring a complex microbial ecosystem. E. aerogenes
BE1/gfp (BE1) and phage UZ1 were added to final concentrations of
8.6±0.89×105 CFU/ml (indicated by the solid line) and 5.8
±1.1×104 PFU/ml (indicated by the dotted line), respectively. The
multiplicity of infection was 0.07 PFU/CFU
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observed that the frequency with which broad-host-range
bacteriophages are isolated is increased by the use of
multiple-host enrichment protocols and that single-host
methods result in selection for narrow-host-range bacter-
iophages. The narrow-host-range of phage UZ1, limited to
E. aerogenes BE1, is also reflected in the fact that there
was no increase in phage titer in the lytic activity assay
containing SHIME suspension without the host strain.
In contrast to antibiotics which have a broad-range
bactericidal effect, the effect of host-specific bacterio-
phages on the commensal microbiota is very focused and
chances of developing secondary infections are avoided
(Chernomordik 1989; Sulakvelidze et al. 2001). A study
by De Gheldre et al. (2001) in Belgian hospitals revealed
that E. aerogenes infections could be assigned to a limited
number of strains, since 74% of all the isolated strains
were identified as E. aerogenes strains BE1 or BE2 (De
Gheldre et al. 2001). Other studies also confirmed that
nosocomial infections in many cases originate from a
single (multiresistant) clone with a regional spread
(Jalaluddin et al. 1998; Mammeri et al. 2001). These
observations point to the potential of therapeutic use of
phage UZ1 against E. aerogenes BE1 infections.
In the development of the model system in this work,
propagation of the phage can be assumed to be solely due
to the lytic activity on a single host strain, namely the gfp-
labeled E. aerogenes BE1. In this context, comparison
with lytic activity in monoculture systems is relevant. The
labeling with the gfp gene and the development of gfp-
specific primers allowed real-time PCR quantification of
E. aerogenes BE1/gfp in the complex gastro-intestinal
microbial community. The marking of bacteria with the
gfp gene is widely used in bacteriology and numerous gfp-
labeled strains are available. Therefore, the use of real-
time PCR for the quantification of gfp-labeled strains, as
presented in this study, can be expanded to other gfp-
labeled strains and different complex ecosystems.
Figure 4 illustrates that there is more proliferation of
phage UZ1 in the lytic activity assay with LB medium
than in the SHIME suspension. The monoculture in LB
medium offers high nutrient levels for optimal growth of
the bacterial strain, resulting in more effective phage
replication, as they employ the host’s cellular machinery
(Middelboe 2000). In the treatment with SHIME suspen-
sion, a lower energy level of the host can be expected, due
to medium composition and competition with other
species. Also, the presence of non-host material of
physical or biological origin interfering with the attach-
ment of the phage to its host can be the cause of the lower
phage replication. The final lytic effect is the result of two
related processes, i.e. bacterial growth rate and phage
replication. Although there was more phage replication in
the E. aerogenes BE1/gfp culture in LB medium, the
observed lytic effect was more pronounced in the reactor
with the SHIME suspension. These results were obtained
within the limited time frame of the lytic activity assays
and at a multiplicity of infection (MOI) of only 0.07 PFU/
CFU. For therapeutic applications, a higher MOI is
favorable and could be achieved as phage stock solutions
of the order of 109 PFU/ml can be produced.
The acidity of the stomach forms a major barrier when
applying phages by oral administration. Phage UZ1 was
stable in the range pH 4–9. At pH 2, there was immediate
and irreversible inactivation of the phage. Slopek et al.
(1983) describe the use of antacid when administering
phages orally. Indeed, the use of an antacid like NaHCO3
proved to be very effective in neutralizing the stomach
acidity and no significant effects of bile salts and
pancreatin were observed. Therefore, the transfer of
phages through the stomach should be designed in a
way which protects the phages against the stomach acidity.
Once the phages arrive in the small and large intestine, it
can be expected that they adequately withstand the
ambient chemical and enzymatic conditions.
Although phage UZ1 persisted not as long in reactor 3
as calculated for the washout of inert particles, it stayed
detectable in the system for 13 days, while the calculated
washout reached the detection limit after 16 days. This
implies that phage UZ1 is relatively resistant to intestinal
conditions but is washed out of this environment in the
absence of the host. There was also some inactivation
observed in the lytic activity assays, where phage UZ1
was more inactivated in the presence of the SHIME
suspension, compared with the reactor with only LB
medium. Interaction with non-host material and adsorption
onto the matrix are plausible causes for these observations.
The SHIME, like other similar in vitro simulators, is a
valuable tool for studying microbiological processes in the
gastro-intestinal system. Until now, interactions with the
human host (like cellular transport mechanisms or the
immune system) were not incorporated in these in vitro
models. With respect to bacteriophages, it is not clear
whether bacteriophages are able to pass the human luminal
barrier. A few studies on laboratory animals suggest that
phages enter the bloodstream after oral administration
within 2–4 h and that they could be found in the internal
organs like liver, spleen, kidney, etc. (Bogovazova et al.
1991, 1992). The development of neutralizing antibodies
after the administration of phages to humans is documen-
ted (Kucharewicz-Krukowska and Slopek 1987). These
antibodies could reduce the effectiveness of phage repli-
cation. Because the kinetics of bacteriophage replication
are much faster than the development of phage-neutraliz-
ing antibodies, this probably will have a limited effect, at
least in the short term (Sulakvelidze et al. 2001).
In conclusion, we developed a model system to study
bacteriophage persistence and lytic activity under simu-
lated intestinal conditions. Bacteriophage UZ1 persisted
for a prolonged period in reactors simulating the different
parts of the large intestine. Furthermore, lytic activity
assays showed proliferation of the bacteriophage; and the
concentration of the gfp-labeled host strain could be
quantified. The SHIME model was found to be a valuable
tool for research in the field of phage ecology and putative
phage therapy.
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